Study of Safety and Efficacy of C-CAR011 in B-NHL Patients
NCT03154775
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Refractory or Relapsed Non-Hodgkin Lymphoma
Interventions
BIOLOGICAL:
C-CAR011
Sponsor
Shanghai AbelZeta Ltd.
Collaborators
[object Object]